Healthcare provider profile · identity verified

Bruce H Leppink, MD

Family Practice · SHOREVIEW, MN · NPI 1356365993

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	449	121
Atorvastatin Calcium	Atorvastatin Calcium	444	113
Lisinopril	Lisinopril	368	95
Rosuvastatin Calcium	Rosuvastatin Calcium	336	88
Pravastatin Sodium	Pravastatin Sodium	282	81
Levothyroxine Sodium	Levothyroxine Sodium	244	53
Tamsulosin Hcl	Tamsulosin Hcl	231	59
Metoprolol Succinate	Metoprolol Succinate	205	56
Trazodone Hcl	Trazodone Hcl	197	58
Metformin Hcl Er	Metformin Hcl	174	51
Losartan Potassium	Losartan Potassium	173	46
Omeprazole	Omeprazole	160	34
Simvastatin	Simvastatin	142	34
Gabapentin	Gabapentin	132	32
Jardiance	Empagliflozin	132	27
Allopurinol	Allopurinol	131	34
Ozempic	Semaglutide	128	19
Olmesartan Medoxomil	Olmesartan Medoxomil	114	29
Eliquis	Apixaban	111	24
Famotidine	Famotidine	108	25
Furosemide	Furosemide	106	24
Hydrochlorothiazide	Hydrochlorothiazide	97	28
Ezetimibe	Ezetimibe	81	21
Metformin Hcl	Metformin Hcl	81	19
Pantoprazole Sodium	Pantoprazole Sodium	81	20
Escitalopram Oxalate	Escitalopram Oxalate	77	18
Metoprolol Tartrate	Metoprolol Tartrate	72	17
Fluticasone Propionate	Fluticasone Propionate	71	28
Finasteride	Finasteride	70	22
Glimepiride	Glimepiride	70	16
Duloxetine Hcl	Duloxetine Hcl	67	16
Mounjaro	Tirzepatide	67	suppressed
Carvedilol	Carvedilol	63	15
Pioglitazone Hcl	Pioglitazone Hcl	60	15
Telmisartan	Telmisartan	58	19
Alendronate Sodium	Alendronate Sodium	54	15
Donepezil Hcl	Donepezil Hcl	54	13
Albuterol Sulfate Hfa	Albuterol Sulfate	53	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	52	16
Quetiapine Fumarate	Quetiapine Fumarate	51	12
Risperidone	Risperidone	51	suppressed
Sertraline Hcl	Sertraline Hcl	51	17
Lorazepam	Lorazepam	50	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	15
Xarelto	Rivaroxaban	48	12
Alfuzosin Hcl Er	Alfuzosin Hcl	44	suppressed
Bupropion Xl	Bupropion Hcl	44	12
Irbesartan	Irbesartan	44	11
Propranolol Hcl	Propranolol Hcl	44	12
Ropinirole Hcl	Ropinirole Hcl	44	suppressed
Clonazepam	Clonazepam	43	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	41	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	suppressed
Warfarin Sodium	Warfarin Sodium	41	12
Tramadol Hcl	Tramadol Hcl	39	13
Farxiga	Dapagliflozin Propanediol	37	suppressed
Mirtazapine	Mirtazapine	37	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Atenolol	Atenolol	33	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Potassium Chloride	Potassium Chloride	28	11
Topiramate	Topiramate	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	17
Valsartan	Valsartan	27	suppressed
Alprazolam	Alprazolam	26	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Cephalexin	Cephalexin	25	18
Clopidogrel	Clopidogrel Bisulfate	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Meloxicam	Meloxicam	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	11
Verapamil Er	Verapamil Hcl	24	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Amoxicillin	Amoxicillin	20	14
Hydroxyzine Pamoate	Hydroxyzine Pamoate	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	11
Ramipril	Ramipril	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Arnuity Ellipta	Fluticasone Furoate	19	suppressed
Prednisone	Prednisone	19	17
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	12
Benazepril Hcl	Benazepril Hcl	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Montelukast Sodium	Montelukast Sodium	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Torsemide	Torsemide	16	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Baclofen	Baclofen	14	suppressed
Carbamazepine Er	Carbamazepine	14	suppressed
Digoxin	Digoxin	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Oxcarbazepine	Oxcarbazepine	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Primidone	Primidone	13	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Minocycline Hcl	Minocycline Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Tymlos	Abaloparatide	12	suppressed
Cefdinir	Cefdinir	11	11
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Scopolamine	Scopolamine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error